(Q48766459)

15 February 2018

title

Virosome-based active immunization targets soluble amyloid species rather than plaques in a transgenic mouse model of Alzheimer's disease. (English)

1 reference

15 February 2018

0 references

0 references

1 reference

Rinaldo Zurbriggen

1

1 reference

15 February 2018

Mario Amacker

2

1 reference

15 February 2018

Andreas R Kammer

3

1 reference

15 February 2018

Nicole Westerfeld

4

1 reference

15 February 2018

Peter Borghgraef

5

1 reference

15 February 2018

Fred Van Leuven

6

1 reference

15 February 2018

Ingrid Van der Auwera

7

1 reference

15 February 2018

Stefaan Wera

8

1 reference

15 February 2018

publication date

1 January 2005

1 reference

15 February 2018

Journal of Molecular Neuroscience

published in

1 reference

15 February 2018

volume

27

1 reference

15 February 2018

issue

2

1 reference

15 February 2018

page(s)

157-166

1 reference

15 February 2018

https://scigraph.springernature.com/pub.10.1385/jmn:27:2:157

exact match

0 references

cites work

Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice

1 reference

12 December 2020

EFRH-phage immunization of Alzheimer's disease animal model improves behavioral performance in Morris water maze trials.

1 reference

12 December 2020

Secretases as targets for the treatment of Alzheimer's disease: the prospects

1 reference

12 December 2020

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

1 reference

12 December 2020

Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice.

1 reference

12 December 2020

A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model

1 reference

12 December 2020

Induction of parasite growth-inhibitory antibodies by a virosomal formulation of a peptidomimetic of loop I from domain III of Plasmodium falciparum apical membrane antigen 1

1 reference

12 December 2020

Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice

1 reference

12 December 2020

IRIV-adjuvanted hepatitis A vaccine: in vivo absorption and biophysical characterization

1 reference

12 December 2020

Reduction of beta-amyloid plaques in brain of transgenic mouse model of Alzheimer's disease by EFRH-phage immunization

1 reference

12 December 2020

Generation of antibodies specific for beta-amyloid by vaccination of patients with Alzheimer disease.

1 reference

12 December 2020

A liposome-based therapeutic vaccine against beta -amyloid plaques on the pancreas of transgenic NORBA mice

1 reference

12 December 2020

Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain

1 reference

12 December 2020

A novel recombinant adeno-associated virus vaccine reduces behavioral impairment and beta-amyloid plaques in a mouse model of Alzheimer's disease

1 reference

12 December 2020

Aging increased amyloid peptide and caused amyloid plaques in brain of old APP/V717I transgenic mice by a different mechanism than mutant presenilin1

1 reference

12 December 2020

beta-site amyloid precursor protein cleaving enzyme 1 increases amyloid deposition in brain parenchyma but reduces cerebrovascular amyloid angiopathy in aging BACE x APP[V717I] double-transgenic mice

1 reference

12 December 2020

Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons.

1 reference

12 December 2020

Aggressive behaviour in transgenic mice expressing APP is alleviated by serotonergic drugs.

1 reference

12 December 2020

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

12 December 2020

Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease

1 reference

12 December 2020

Reduction of amyloid load and cerebral damage in a transgenic mouse model of Alzheimer's disease by treatment with a beta-sheet breaker peptide.

1 reference

12 December 2020

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

1 reference

12 December 2020

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

1 reference

12 December 2020

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

1 reference

12 December 2020

Immunogenicity and adverse effects of inactivated virosome versus alum-adsorbed hepatitis A vaccine: a randomized controlled trial

1 reference

12 December 2020

Identifiers

DOI

10.1385/JMN:27:2:157

1 reference

15 February 2018

Dimensions Publication ID

1011007546

0 references

1 reference

15 February 2018